# FDA Inspection 1227222 - Carter BloodCare - January 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare/c5ca7d8d-655f-400a-b66e-2e42bacdc1eb
Source feed: FDA_Inspections

> FDA Inspection 1227222 for Carter BloodCare on January 11, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1227222
- Company Name: Carter BloodCare
- Inspection Date: 2024-01-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1272556 - 2025-06-05](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/40b58395-ed1b-4d08-8972-8dae0d44e2fc)
- [FDA Inspection 1088131 - 2019-04-05](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/fb8066cd-1753-4bbf-9b44-cb585183840c)
- [FDA Inspection 1029042 - 2017-08-02](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/316e7140-0473-4d84-8de8-d9810c76aa8d)
- [FDA Inspection 871589 - 2014-03-17](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/c8eeb1fc-8e1d-42e0-a8a6-76e1186ddb51)
- [FDA Inspection 775769 - 2012-04-05](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/0f6dfce1-b46d-419b-bfa7-5d0475157106)

Company: https://www.keypedia.com/companies/carter-bloodcare/1906a188-d50d-4477-9ca3-3de9d82111e8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d